Label: ASPERCREME LIDOCAINE WITH ROSEMARY AND MINT- lidocaine hydrochloride cream

  • Category: HUMAN OTC DRUG LABEL

Drug Label Information

Updated January 10, 2024

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

  • SPL UNCLASSIFIED SECTION

    Aspercreme Lidocaine with Rosemary & Mint

    Drug Facts

  • Active ingredient

    Lidocaine HCl 4%

  • Purpose

    Topical anesthetic

  • Use

    for the temporary relief of pain

  • Warnings

    For external use only

    Do not use

    • in large quantities
    • on wounds or on irritated or damaged skin
    • with a heating pad

    When using this product

    • use only as directed
    • do not bandage tightly
    • avoid contact with eyes and mucous membranes
    • do not expose the area to local heat or to direct sunlight

    Stop use and ask a doctor if

    • condition worsens or symptoms persist for more than 7 days
    • symptoms clear up and occur again within a few days
    • redness is present or excessive skin irritation occurs
    • you experience severe burning pain, swelling, or blistering where the product was applied

    If pregnant or breast-feeding,

    ask a health professional before use.

    Keep out of reach of children.

    If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    • adults and children 12 years of age and older:
      • apply a thin layer to affected area every 6 to 8 hours, not more than 3 to 4 times daily
      • massage until thoroughly absorbed into skin
      • wash hands thoroughly with soap and water after each use
    • children under 12 years of age: ask a doctor
  • Inactive ingredients

    water, cetearyl alcohol, alcohol denat., ceteth-20 phosphate, dimethicone, caprylyl methicone, dicetyl phosphate, C30-45 alkyl cetearyl dimethicone crosspolymer, triethyl citrate, glycerl stearate, potassium hydroxide, aloe barbadensis leaf juice, hydroxyacetophenone, fragrance, acrylates/C10-30 alkyl acrylate crossploymer, ethylhexylglycerin, panthenol, tocopheryl acetate, magnesium ascorbyl phosphate

    Child-resistant packaging. Close cap tightly after use.

  • Principal Display Panel

    NEW!
    MAX STRENGTH
    Aspercreme®
    WITH 4% LIDOCAINE
    PAIN RELIEF CREAM
    NUMBS
    AWAY PAIN
    #1
    LIDOCAIN
    BRAND*
    FAST ACTING
    TARGETS NERVES
    FRESH
    ROSEMARY MINT
    SCENT
    With
    ROSEMARY
    & MINT
    Essential Oils
    *Among OTC topical analgesics.
    NET WT 1.75 OZ (49.6 g)

    Principal Display Panel
NEW!
MAX STRENGTH
Aspercreme®
WITH 4% LIDOCAINE
PAIN RELIEF CREAM
NUMBS
AWAY PAIN
#1
LIDOCAIN
BRAND*
FAST ACTING
TARGETS NERVES
FRESH
ROSEMARY MINT
SCENT
With
ROSEMARY
& MINT
Essential Oils
*Among OTC topical analgesics.
NET WT 1.75 OZ (49.6 g)

  • INGREDIENTS AND APPEARANCE
    ASPERCREME LIDOCAINE WITH ROSEMARY AND MINT 
    lidocaine hydrochloride cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:41167-0565
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987) LIDOCAINE HYDROCHLORIDE ANHYDROUS4 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
    ALCOHOL (UNII: 3K9958V90M)  
    CETETH-20 PHOSPHATE (UNII: 921FTA1500)  
    DIMETHICONE (UNII: 92RU3N3Y1O)  
    CAPRYLYL TRISILOXANE (UNII: Q95M2P1KJL)  
    DIHEXADECYL PHOSPHATE (UNII: 2V6E5WN99N)  
    C30-45 ALKYL CETEARYL DIMETHICONE CROSSPOLYMER (UNII: 4ZK9VP326R)  
    TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  
    GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
    POTASSIUM HYDROXIDE (UNII: WZH3C48M4T)  
    ALOE VERA LEAF (UNII: ZY81Z83H0X)  
    HYDROXYACETOPHENONE (UNII: G1L3HT4CMH)  
    CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED) (UNII: 59TL3WG5CO)  
    ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
    PANTHENOL (UNII: WV9CM0O67Z)  
    .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
    MAGNESIUM ASCORBYL PHOSPHATE (UNII: 0R822556M5)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:41167-0565-01 in 1 CARTON01/15/2024
    149.6 g in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01701/15/2024
    Labeler - Chattem, Inc. (003336013)